Alectinib Dose Escalation Reinduces Central Nervous System Responses in Patients with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer Relapsing on Standard Dose Alectinib.
about
Are immune checkpoint blockade monoclonal antibodies active against CNS metastases from NSCLC?-current evidence and future perspectives.Treatment of ALK-rearranged non-small cell lung cancer: A review of the landscape and approach to emerging patterns of treatment resistance in the Australian context.Alectinib for ALK-positive non-small-cell lung cancer.Treating patients with ALK-rearranged non-small-cell lung cancer: mechanisms of resistance and strategies to overcome it.Optimizing treatment for patients with anaplastic lymphoma kinase-positive lung cancer.Sequencing brain metastases and opportunities for targeted therapies.A Case of Metastatic Atypical Neuroendocrine Tumor with ALK Translocation and Diffuse Brain Metastases.ALK on my mind: alectinib takes an early lead in managing intracranial disease in non-small cell lung cancer with ALK rearrangements.Targeted therapy for leptomeningeal metastases in non-small cell lung cancer - Changing treatment paradigms.ALK in Neuroblastoma: Biological and Therapeutic Implications.Tumor Resistance against ALK Targeted Therapy-Where It Comes From and Where It Goes.Alectinib in the treatment of ALK-positive non-small cell lung cancer: an update on its properties, efficacy, safety and place in therapy
P2860
Q37584395-E3555390-A517-481D-8BF8-FB482431A9F7Q38631019-128C6C4C-12AB-4240-AA19-42B9EE901390Q38846027-5C719195-63CB-4BAD-A0CB-A56177BA8CFDQ39039088-EAAE440C-2883-4BDD-B3BA-9663E40EEFB6Q39128273-EF85C1DD-DCFF-4AE0-8EB2-212873A36871Q39177404-20EA75CB-2EC7-4A33-AAFE-A9221C370231Q40996780-816BA631-28B2-4D8D-A54D-38E2A7FFC87FQ42359754-17DA1F46-5921-4897-BD3B-CF666350E92AQ49894049-30F82E66-C33D-4670-B29D-2BE031D84EAAQ52324760-0FDD3557-7FF0-420A-B63F-93A8B33115A0Q52679023-61891162-A154-4A1C-815B-C76CEBF71A8BQ58802261-2B8682C6-DE9B-464A-A27B-970207A38A11
P2860
Alectinib Dose Escalation Reinduces Central Nervous System Responses in Patients with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer Relapsing on Standard Dose Alectinib.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Alectinib Dose Escalation Rein ...... ng on Standard Dose Alectinib.
@ast
Alectinib Dose Escalation Rein ...... ng on Standard Dose Alectinib.
@en
type
label
Alectinib Dose Escalation Rein ...... ng on Standard Dose Alectinib.
@ast
Alectinib Dose Escalation Rein ...... ng on Standard Dose Alectinib.
@en
prefLabel
Alectinib Dose Escalation Rein ...... ng on Standard Dose Alectinib.
@ast
Alectinib Dose Escalation Rein ...... ng on Standard Dose Alectinib.
@en
P2093
P2860
P50
P1476
Alectinib Dose Escalation Rein ...... ng on Standard Dose Alectinib.
@en
P2093
Alice T Shaw
Andrew S Chi
Jennifer Logan
Justin F Gainor
Kevin S Oh
P2860
P304
P356
10.1016/J.JTHO.2015.10.010
P577
2015-12-18T00:00:00Z